The Predictive Value of Neutrophil-to-Lymphocyte Ratio for Hodgkin’s Lymphoma Diagnosis in Patients with Asymptomatic Cervical Lymphadenopathy

Evaluation of the predictive role of neutrophil/lymphocyte ratio in the diagnosis of lymphoma in patients with asymptomatic and ısolated cervical lymphadenopathy

“…Before the excisional biopsy, the NLR was found to be significantly higher in the Hodgkin lymphoma group than in the RAL group. 20 In our study, the median NLR 3 was detected in the HL arm. In this study, the detection of NLR in the HL group higher than our study was thought to be due to the fact thatt some of the cases in this study may be at the advanced stage.…”

“…The presence of LAP larger than 1 cm in the cervical region and present for at least 4 weeks requires further investigation. 20 , 21 …”

“… 25 However, one study in the literature investigated the diagnostic predictive value of NLR before excisional biopsy in HL patients. 20 In our study, we compared NLR according to the RAL group in patients diagnosed with NHL and HL as a result of the biopsy.…”

Preoperative Blood Inflammatory Markers for the Differentiation of Uterine Leiomyosarcoma from Leiomyoma

“…11 However, few studies have investigated the diagnostic values of markers of systemic inflammation in different cancers (Table 5). In non-gynecologic cancers, NLR has been suggested to predict the presence of Hodgkin lymphoma, glioma, prostate cancer, or cartilaginous tumors (enchondroma and low-grade chondrosarcoma), 10,[37][38][39][40] whereas in gynecologic cancers, we have reported on the usefulness of NLR as a diagnostic marker for the presence of EOC. 8 Kim et al described the efficacy of NLR for the preoperative diagnosis of uterine sarcomas and suggested that NLR (≥2.12) might provide a more useful and costeffective means than serum CA-125 for their preoperative differentiation.…”

Impact on the survival of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and monocyte-lymphocyte ratio on prognosis in children with Hodgkin lymphoma

“…These markers include absolute neutrophil counts to absolute lymphocyte counts ratio )NLR(, absolute platelet counts to absolute lymphocyte counts ratio )PLR(, and absolute monocyte counts to absolute lymphocyte counts ratio )MLR( and so on. [6][7][8][9][10][11][12][13][14][15][16][17][18] However, there are few reports on the use of these markers in childhood malignant diseases. Furthermore, several studies have highlighted its effects on prognosis in children with malignant diseases.…”